Side-effects: latest news

Side-effects resources

  • Nausea and vomiting

    Nausea and vomiting are possible side-effects of some HIV drugs.Most often, these side-effects will go away after a few weeks of taking the drug.Medicines called...

    From: Factsheets

    Information level Level 2
  • Changing HIV treatment

    Talk to your doctor if you are concerned about any side-effects you are experiencing.If you are having problems taking your HIV treatment, it’s important to be honest...

    From: Factsheets

    Information level Level 2
  • Diarrhoea

    Diarrhoea is common in people with HIV, particularly those with a low CD4 count.It can be caused by infection and is also a possible side-effect of some...

    From: Factsheets

    Information level Level 2
  • Side-effects checker

    A tool to help you talk to your healthcare team about any side-effects or symptoms that you have....

    From: Resources

  • Tiredness and fatigue

    Illnesses and drug side-effects can contribute to fatigue.People often report an increase in their energy levels after starting HIV treatment.A healthy balanced diet may help...

    From: Factsheets

    Information level Level 2
  • Side effects

    The most common side effects are the result of your body getting used to a new drug. After a few weeks, these side effects usually...

    From: The basics

    Information level Level 1
  • Antiretroviral drugs chart

    A one-page reference guide to the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions....

    From: Antiretroviral drugs chart

    Information level Level 1
  • Managing side-effects that interfere with eating

    Like all medicines, the drugs used to treat HIV can cause side-effects. These are most likely to occur when you first start taking a drug, but...

    From: Booklets

    Information level Level 2
  • Sleep

    Sleep is essential to physical and mental health.Anxiety, depression, drug or alcohol use, and illness can contribute to sleep problems.Simple lifestyle changes may be enough to...

    From: Factsheets

    Information level Level 2
  • Lipodystrophy

    Lipodystrophy is a side-effect of some older anti-HIV drugs which are now rarely used.Lipodystrophy includes both weight gain and weight loss.It is common for people...

    From: Factsheets

    Information level Level 2
  • My drugs chart

    My drugs chart provides information on all the anti-HIV drugs currently licensed for use in Europe.Select your chosen drugs and drag them onto the area...

    From: My drugs chart

  • HIV treatment in women

    The evidence available suggests that HIV treatment works well for women. Unless you are pregnant, the recommendations for HIV treatment are the same for both women and...

    From: Booklets

    Information level Level 2
  • Side-effects

    Like all medications, anti-HIV drugs can cause side-effects and these can be a reason why people don’t take their treatment properly. The risk of side-effects can vary between...

    From: Booklets

    Information level Level 2
  • Side-effects

    The booklet provides information about possible side-effects of HIV treatment. ...

    From: Booklets

    Information level Level 2
  • Side-effects

    Information on the side-effects associated with anti-HIV treatments and other drugs, including advice on how to cope with them, and whether treatment should be stopped...

    From: HIV treatments directory

    Information level Level 4
  • Effect of genetic variation on side-effects of HIV drugs

    In addition to drug levels, the other major area of research interest in pharmacogenetics is the association of human genetic variation with the incidence or...

    From: HIV treatments directory

    Information level Level 4

Side-effects features

Side-effects in your own words

Side-effects news from aidsmap

More news

Side-effects news selected from other sources

  • New recommendations aim to help pregnant women with HIV make informed choices

    New recommendations on antiretroviral drugs for pregnant women living with HIV can help women make more informed choices about benefits and harms, say a panel of international experts in The BMJ today. The panel recommend older drug combinations instead of the most widely used regimens to help reduce the risk of premature birth and neonatal death - which almost all women said they were extremely keen to avoid.

    12 September 2017 | EurekAlert
  • New Data Shows Dramatic Reduction in Chronic Diarrhea Episodes with Crofelemer (Mytesi) Treatment

    Napo Pharmaceuticals, Inc., and Jaguar Animal Health, Inc. (Jaguar), announced today the results of a supplemental analysis of the long-term trial of crofelemer (Mytesi®) in patients with chronic HIV-related diarrhea. The analysis revealed a mean decrease of over 70 percent in diarrhea episodes versus baseline and over 50 percent of patients with complete resolution of their diarrhea.

    27 July 2017 | Napo Pharmaceuticals press release
  • Medicine information leaflets 'too scary', say experts

    A more balanced view of the benefits and potential side effects is being called for in a report.

    20 June 2017 | BBC Health
  • Unexpected side effects with generic abacavir – and potential for rare reactions to other generic ARVs

    Several anecdotal reports of mouth ulcers have recently been reported in people switching to generic abacavir in the UK. This should highlight awareness of the potential of likely-rare new side effects, even when both formulations have been approved as bioequivalent.

    23 May 2017 | HIV i-Base
  • Darunavir Associated with Heart Disease

    But atazanavir use in HIV patients not linked to cardiovascular disease.

    20 February 2017 | MedPage Today HIV/AIDS
  • How a gene test can solve side effects linked to ARV drugs in Africa

    Studies have shown that people who react particularly badly to efavirenz have a particular gene variant that messes with an enzyme responsible for processing the drug in their bodies.

    01 February 2017 | The Conversation
  • Top 10 HIV Clinical Developments of 2016

    In typical years, a noteworthy development in the world of HIV would be the result of a landmark clinical trial or perhaps a gem of a lab study with a novel finding. But, 2016 was not typical. What made the most difference for people living with HIV and their health care providers this past year was less a paper published or presented than major shifts in our thinking about how best to prevent and manage HIV infection.

    02 December 2016 | The Body Pro
  • Efavirenz Side Effects Include Suicide; It Could Have Been Me

    I was on efavirenz for years. Within six months of dropping the drug altogether, I normalized. For the first time in years, I was not flooded with suicidal thoughts, addictions and crippling mental health woes.

    31 October 2016 | The Body
  • Two Experts Discuss HIV, Abdominal Fat and Body Shape Changes

    Watch's HIV and Aging Expert Nelson Vergel interview Dr. Stephen Grinspoon, Professor at Harvard Medical School and the Director of a Program in Nutritional Metabolism at Massachusetts General Hospital about the causes of body shape changes in HIV -- and most importantly, what you can do about them.

    24 August 2016 | The Body
  • Gilead defeats AIDS activists who claimed the company manipulated patents

    Gilead Sciences won a victory last week when a federal court judge tossed a lawsuit in which an AIDS activist group accused the drug maker of manipulating the patent system in order to thwart competition for its HIV medicines. At issue was tenofovir, or TDF, which Gilead is replacing with a modified version known as TAF.

    13 July 2016 | STAT
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.